“EUROIMMUN” Anti-Glutamate receptor (type NMDA) IIFT - Taiwan Registration 39154efa9e651cd0b163bcd3a02ab2a0
Access comprehensive regulatory information for “EUROIMMUN” Anti-Glutamate receptor (type NMDA) IIFT in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 39154efa9e651cd0b163bcd3a02ab2a0 and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The authorized representative in Taiwan is EUROIMMUN (SOUTH EAST ASIA) PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
39154efa9e651cd0b163bcd3a02ab2a0
Ministry of Health Medical Device Import No. 031145
DHA05603114502
Product Details
This product is used for in vitro qualitative or semi-quantitative detection of anti-glutaminate receptor (NMDA type) antibody immunoglobulin IgG antibodies in human serum, plasma or cerebrospinal fluid (CSF) samples.
C Immunology and microbiology devices
C5660 Multiple autologous antibody immunoassay system
Imported from abroad
Dates and Status
Jun 12, 2018
Jun 12, 2028

